<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Development of well-defined nanomedicines is critical for their successful clinical translation </plain></SENT>
<SENT sid="1" pm="."><plain>A simple synthesis and purification procedure is established for chemically cross-linked polyion complexes of Cu/Zn <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD1) or catalase with a cationic <z:chebi fb="6" ids="53511">block copolymer</z:chebi>, <z:chebi fb="8" ids="32772">methoxy</z:chebi>-<z:chebi fb="0" ids="46793">poly(ethylene glycol)</z:chebi>-block-poly(<z:chebi fb="0" ids="53633">L-lysine hydrochloride</z:chebi>) (<z:chebi fb="77" ids="46793">PEG</z:chebi>-pLL₅₀) </plain></SENT>
<SENT sid="2" pm="."><plain>Such complexes, termed cross-linked nanozymes (cl-nanozymes) retain catalytic activity and have narrow size distribution </plain></SENT>
<SENT sid="3" pm="."><plain>Moreover, their cytotoxicity is decreased compared to non-cross-linked complexes due to suppression of release of the free <z:chebi fb="6" ids="53511">block copolymer</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>SOD1 cl-nanozymes exhibit prolonged ability to scavenge experimentally induced reactive oxygen species (ROS) in cultured brain microvessel endothelial cells and central neurons </plain></SENT>
<SENT sid="5" pm="."><plain>In vivo they decrease <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion-induced tissue injury and improve sensorimotor functions in a rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model after a single intravenous (i.v.) injection </plain></SENT>
<SENT sid="6" pm="."><plain>Altogether, well-defined cl-nanozymes are promising modalities for attenuation of <z:mp ids='MP_0003674'>oxidative stress</z:mp> after brain injury </plain></SENT>
</text></document>